Effect of the HIV protease inhibitor amprenavir on the growth and differentiation of primary gingival epithelium

Joint United Nations Programme on HIV AIDS. Global summary of the AIDS epidemic. (Updated December 2007. Accessed December 2007.) Available from http://data.unaids.org/pub/EPISlides/2007/2007_epiupdate_en.pdf.

Moniaci D. , Greco D. , Flecchia G. , Raitieri R. , Sinicco A. Epidemiology, clinical features and prognostic value of HIV-1 related oral lesions. J Oral Pathol Med 1990; 19: 477–481.

Bravo I.M. , Correnti M. , Escalona L. Prevalence of oral lesions in HIV patients related to CD4 cell count and viral load in Venezuelan population. Med Oral Patol Oral Cir Bucal 2006; 11: E33–E39.

Gortmaker S.L. , Hughes M. , Cervia J. Effects of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1. N Engl J Med 2001; 345: 1522–1528.

Granados J.M.S. , Amador J.T.R. , Miguel S.F. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus infected children. Pediatr Infect Dis J 2003; 22: 863–867.

Greenspan D. , Canchola A.J. , MacPhail A. , Cheikh B. , Greenspan J.S. Effect of highly active antiretroviral therapy on frequency of oral warts. Lancet 2001; 357: 1411–1412.

Greenspan J.S. , Greenspan D. The epidemiology of the oral lesions of HIV infection in the developed world. Oral Dis 2002; 8: 34–39.

Hodgson T.A. , Greenspan D. , Greenspan J.S. Oral leasions of HIV disease and HAART in industrialized countries. Adv Dent Res 2006; 19: 57–62.

Scully C. , Dios P.D. Orofacial effects of antiretroviral therapies. Oral Dis 2001; 7: 205–210.

Dios P.D. , Scully C. Adverse effects of antiretroviral therapy: focus on orofacial effects. Expert Opin Drug Saf 2002; 1: 307–317.

Fagot J.P. , Mockenhaupt M. , Bouwes-Bavinck J.N. , Naldi L. , Viboud C. , Roujeau J.C. Nevirapine and the risk of Stevans– Johnson syndrome or toxic epidermal necrolysis. AIDS 2001; 15: 1843–1848.

Jordan R.A. [Implications of antiretroviral therapy in oral medicine – a review of literature]. Schweiz Monatsschr Zahnmed 2007; 117: 1210–1216. German.

Fung H.B. , Kirschenbaum H.L. , Hameed R. Amprenavir: a new human immunodeficiency virus type 1 protease inhibitor. Clin Ther 2000; 22: 549–572.

Goodgame J.C. , Pottage J.C. Jr. , Jablonowski H. Amprenavir in combination with lamivudine and zidovudine versus lamivudine and zidovudine alone in HIV-1-infected antiretroviral-naive adults. Antivir Ther 2000; 5: 215–225.

Rotunda A. , Hirsch R.J. , Scheinfeld N. , Weinberg J.M. Severe cutaneous reactions associated with the use of human immunodeficiency virus medications. Acta Derm Venereol 2003; 83: 1–9.

Flint S.R. , Tappuni A. , Leigh J. , Schmidt-Westhausen A.M. , MacPhail L. Markers of immunodeficiency and mechanisms of HAART therapy on oral lesions. Adv Dent Res 2006; 19: 146–151.

Hawkins T. HIV drug resistance and you. The limitations of drug resistance testing. Many factors influence the results. Posit Aware 2006; Spec no: 13–16.

Presland R.B. , Dale B.A. Epithelial structural proteins of the skin and oral cavity: function in health and disease. Crit Rev Oral Biol Med 2000; 11: 383–408.

Squier C.A. , Kremer M.J. Biology of oral mucosa and esophagus. J Natl Cancer Inst Monogr 2001; 29: 7–15.

Franke W.W. , Schiller D.L. , Moll R. Diversity of cytokeratins: differentiation specific expression of cytokeratin polypeptides in epithelial cells and tissues. J Mol Biol 1981; 153: 933–939.

Moll R. , Franke W.W. , Schiller D.L. , Geiger B. , Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982; 31: 11–24.

Watanabe S. , Osumi M. , Ohnishi T. , Ichikawa E. , Takahashi H. Changes in cytokeratin expression in epidermal keratinocytes during wound healing. Histochem Cell Biol 1995; 103: 425–433.

Paladini R.D. , Takahashi K. , Bravo N.S. , Coulombe P.A. Onset of re-epithelialization after skin injury correlates with a reorganization of keratin filaments in wound edge keratinocytes: defining a potential role for keratin 16. J Cell Biol 1996; 132: 381–397.

Bloor B.K. , Seddon S.V. , Morgan P.R. Gene expression of differentiation specific keratins (K4, K13, K1 and K10) in oral non-dysplastic keratoses and lichen planus. J Oral Pathol Med 2000; 29: 376–384.

Bonan P.R.F. , Kaminagakura E. , Pires F.R. Cytokeratin expression in initial oral mucositis of head and neck irradiated patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 101: 205–211.

Meyers C. Organotypic (raft) epithelial tissue culture system for the differentiation-dependent replication of papillomavirus. Methods Cell Sci 1996; 18: 201–210.

Meyers C. , Frattini M.G. , Hudson J.B. , Laimins L.A. Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation. Science 1992; 257: 971–973.

Tomakidi P. , Fusenig N.E. , Kohl A. , Komposch G. Histomorphological and biochemical differentiation capacity in organotypic co-cultures of primary gingival cells. J Periodontal Res 1997; 32: 388–400.

Klausner M. , Ayehunie S. , Breyfogle B.A. , Wertz P.W. , Bacca L. , Kubilus J. Organotypic human oral tissue models for toxicological studies. Toxicol In Vitro 2007; 21: 938–949.

Mackenzie I.C. , Rittman G. , Gao Z. , Leigh I. , Lane E.B. Patterns of cytokeratin expression in human gingival epithelia. J Periodontal Res 1991; 26: 468–478.

Eichner R. , Bonitz P. , Sun T.T. Classification of epidermal keratins according to their immunoreactivity, isoelectric point, and mode of expression. J Cell Biol 1984; 98: 1388–1396.

Purkis P.E. , Steel J.B. , Mackenzie I.C. , Nathrath W.B. , Leigh I.M. , Lane E.B. Antibody markers of basal cells in complex epithelia. J Cell Sci 1990; 97: 39–50.

Weiss R.A. , Eichner R. , Sun T.T. Monoclonal antibody analysis of keratin expression in epidermal diseases: a 48 and 56-kdalton keratin as molecular marker for hyperproliferative keratinocytes. J Cell Biol 1984; 98: 1397–1406.

Bravo R. , Frank R. , Blundell P.A. , Macdonald-Bravo H. Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta. Nature 1987; 326: 515–517.

Pagano M. , Pepperkok R. , Verde F. , Ansorge W. , Draetta G. Cyclin A is required at two points in the human cell cycle. EMBO J 1992; 11: 961–971.

Desdouets C. , Sobczak-Thepot J. , Murphy M. , Brechot C. Cyclin A: function and expression during cell proliferation. Prog Cell Cycle Res 1995; 1: 115–123.

Bernerd F. , Magnaldo T. , Darmon M. Delayed onset of epidermal differentiation in psoriasis. J Invest Dermatol 1992; 98: 902–910.

Fuchs E. , Green H. Changes in keratin gene expression during terminal differentiation of the keratinocytes. Cell 1980; 19: 1033–1042.

dos Santos J.N. , de Sousa S.O.M. , Nunes F.D. , Sotto M.N. , de Araujo V.C. Altered cytokeratin expression in actinic cheilitis. J Cutan Pathol 2003; 30: 237–241.

Bloor B.K. , Tidman N. , Leigh I.M. Expression of keratin K2e in cutaqneous and oral lesions: association with keratinocytes activation, proliferation and keratinization. Am J Pathol 2003; 162: 963–975.

Wetzels R.H. , Kujipers H.J. , Lane E.B. Basal specific and hyperproliferation-related keratins in human breast cancer. Am J Pathol 1991; 138: 751–763.

Morgan P.R. , Su L. Intermediate filaments in oral neoplasia. 1. Oral cancer and epithelial dysplasia. Eur J Cancer B Oral Oncol 1994; 30: 160–166.

Usui M.L. , Underwood R.A. , Mansbridge J.N. , Muffley L.A. , Carter W.G. , Olerud J.E. Morphological evidence for the role of suprabasal keratinocytes in wound reepithelialization. Wound Repair Regen 2005; 13: 468–479.

Mansbridge J.N. , Knapp A.M. Changes in keratinocytes maturation during wound healing. J Invest Dermatol 1987; 89: 253–263.

Stoler A. , Kopan R. , Duvic M. , Fuchs E. Use of monospecific antisera and cRNA probes to localize the major changes in keratin expression during normal and abnormal epidermal differentiation. J Cell Biol 1988; 107: 427–446.

Lundqvist K. , Schmidtchen A. Cyclin A expression in chronic leg ulcers. Acta Derm Venereol 2006; 86: 61–62.

Thomson P.J. , Goodson M.L. , Booth C. , Cragg N. , Hamadah O. Cyclin A activity predicts clinical outcome in oral precancer and cancer. Int J Oral Maxillofac Surg 2006; 35: 1041–1046.

Nelson W.G. , Sun T.T. The 50- and 58-kdalton keratin classes as molecular markers for stratified squamous epithelia: cell culture studies. J Cell Biol 1983; 97: 244–251.

Celis J.E. , Celis A. Cell cycle dependent variations in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cells: subdivision of S phase. Proc Natl Acad Sci U S A 1985; 82: 3262–3266.

Zuber M. , Tan E.M. , Ryoji M. Involvement of proliferating cell nuclear antigen (cyclin) in DNA replication in living cells. Mol Cell Biol 1989; 9: 57–66.

Bujia J. , Sudhoff H. , Holly A. , Hildmann H. , Kastenbauer E. Immunohistochemical detection of proliferating cell nuclear antigen in middle ear cholesteatoma. Eur Arch Otorhinolaryngol 1996; 253: 21–24.

Girod S.C. , Pfeiffert P. , Ries J. , Papet H.D. Proliferative activity and loss of function of tumour suppressor genes as biomarkers in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma. Br J Oral Maxillofac Surg 1998; 36: 252–260.

King M.D. , Reznik D.A. , O'Daniela C.M. Human papillomavirus associated oral warts among human immunodeficiency virus seropositive patients in the area of highly active antiretroviral therapy: an emerging infection. Clin Infect Dis 2002; 34: 641–648.

Cameron J.E. , Mercante D. , O'Brien M. The impact of highly active antiretroviral therapy and immunodeficiency on human papillomavirus infection of the oral cavity of human immunodeficiency virus seropositive adults. Sex Transm Dis 2005; 32: 703–709.